Showing 561 - 580 results of 910 for search '"Dementia"', query time: 0.06s Refine Results
  1. 561

    Using Health Utility Index (HUI) for Measuring the Impact on Health-Related Quality of Life (HRQL) Among Individuals with Chronic Diseases by Frank Mo, Bernard C.K. Choi, Felix C.K. Li, Joav Merrick

    Published 2004-01-01
    “…Urinary incontinence, Alzheimer/other dementia, effects of stroke, cancers, thyroid condition, and back problems have a moderate impact. …”
    Get full text
    Article
  2. 562

    Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease by Geetika Nehra, Bryan J. Maloney, Rebecca R. Smith, Wijitra Chumboatong, Erin L. Abner, Peter T. Nelson, Björn Bauer, Anika M. S. Hartz

    Published 2025-01-01
    “…Methods We used postmortem brain tissue and plasma samples from 19 participants: 9 CNI and 10 AD dementia patients who had come to autopsy from the University of Kentucky AD Research Center (UK-ADRC) community-based cohort; all cases with dementia had confirmed severe ADNC. …”
    Get full text
    Article
  3. 563

    Presence and Absence in Margaret Atwood’s Dearly by Pilar Sánchez-Calle

    Published 2025-01-01
    “…Many of these poems are dedicated to her partner Graeme Gibson, who was diagnosed with vascular dementia in 2017 and passed away in 2019. Through close readings and formal analysis, I aim to demonstrate how these elegiac poems articulate a psychic landscape of mourning where separation after death is rejected and an alternative space for reunion with the deceased is created. …”
    Get full text
    Article
  4. 564

    A Case of Tick-Borne Paralysis in a Traveling Patient by Kevin Ha, Kathryn Lewis, Vandan Patel, Jennifer Grinceri

    Published 2019-01-01
    “…An 88-year-old man with dementia and dyslipidemia presented with new onset gait instability and was admitted for suspected cerebellar stroke. …”
    Get full text
    Article
  5. 565

    Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health by Franco Cavaleri, Emran Bashar

    Published 2018-01-01
    “…The low-carbohydrate high-fat diet (LCHFD), also known as the ketogenic diet, has cycled in and out of popularity for decades as a therapeutic program to treat metabolic syndrome, weight mismanagement, and drug-resistant disorders as complex as epilepsy, cancer, dementia, and depression. Despite the benefits of this diet, health care professionals still question its safety due to the elevated serum ketones it induces and the limited dietary fiber. …”
    Get full text
    Article
  6. 566

    Uma carta para Mark Freeman sobre a “promessa trágica” de doenças neurodegenerativas by Will Lucas Silva Pena

    Published 2021-05-01
    “…Nela, debato elementos que o autor traz em seu artigo Beyond narrative: dementia’s tragic promise (2008a), em especial a associação entre “narrativas”, “subjetividade” e “processos de adoecimento”. …”
    Get full text
    Article
  7. 567

    Clinical Interaction between Brain and Kidney in Small Vessel Disease by Masaki Mogi, Masatsugu Horiuchi

    Published 2011-01-01
    “…Recently, changes in the vascular system of the brain have been shown to contribute to the onset and progression of cognitive impairment, not only vascular dementia but also Alzheimer's disease. Patients with CKD are also reported to have higher risk of impaired cognitive function in the future compared with non-CKD subjects. …”
    Get full text
    Article
  8. 568

    Role of Neuroinflammation in Adult Neurogenesis and Alzheimer Disease: Therapeutic Approaches by Almudena Fuster-Matanzo, María Llorens-Martín, Félix Hernández, Jesús Avila

    Published 2013-01-01
    “…Neuroinflammation, a specialized immune response that takes place in the central nervous system, has been linked to neurodegenerative diseases, and specially, it has been considered as a hallmark of Alzheimer disease, the most common cause of dementia in the elderly nowadays. Furthermore, neuroinflammation has been demonstrated to affect important processes in the brain, such as the formation of new neurons, commonly known as adult neurogenesis. …”
    Get full text
    Article
  9. 569

    CLOCK Genes and Circadian Rhythmicity in Alzheimer Disease by J. Thome, A. N. Coogan, A. G. Woods, C. C. Darie, F. Häßler

    Published 2011-01-01
    “…Presently, more and more data are emerging demonstrating how alterations of the CLOCK gene system might contribute to the pathophysiology of AD and other forms of dementia. At the same time, the impact of neuropsychiatric medication on CLOCK gene expression is under investigation.…”
    Get full text
    Article
  10. 570

    Positron emission tomography tracers for synucleinopathies by Jie Xiang, Zhentao Zhang, Shengxi Wu, Keqiang Ye

    Published 2025-01-01
    “…Abstract Synucleinopathies, such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy, are characterized by the aggregation of α-synuclein. …”
    Get full text
    Article
  11. 571

    Dietary inflammatory index and disability among older adults in Guangzhou: a cross-sectional analysis by Junbin Liao, Junbin Liao, Wenfeng Cai, Danrong Lin, Yuanyun Xiao, Yanxi Liu, Yahui Wang, Yuquan Zhong, Fan Xiao, Heng Fang, Yilu Yao, Yunfeng Lin, Jiewen Su, Siyu Sun, Bo Zhang, Yan Wang, Wei Zhu, Wei Zhu

    Published 2025-01-01
    “…After adjusting for confounding factors, a higher DII was linked to a greater degree of disability, with the highest DII quartile showing a notably higher risk (OR = 2.61, 95% CI = 1.21–5.61) compared to the lowest quartile.ConclusionLack of exercise, previous exercise, stroke, and dementia are correlated with increased disability among older adults. …”
    Get full text
    Article
  12. 572

    Cognitive disorders in patients with atrial fibrillation by O.A. Yepanchintseva, A.S. Solonovych, O.S. Solonovych

    Published 2023-06-01
    “…AF is associated with an increased risk of dementia in patients with and without history of stroke. …”
    Get full text
    Article
  13. 573

    Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies by Shuguang Wang, Zuning Liao, Qiying Zhang, Xinyuan Han, Changqing Liu, Jin Wang

    Published 2025-01-01
    “…Alzheimer’s disease (AD) is the most common neurodegenerative disorder, accounting for approximately 70% of dementia cases worldwide. Patients gradually exhibit cognitive decline, such as memory loss, aphasia, and changes in personality and behavior. …”
    Get full text
    Article
  14. 574
  15. 575

    Ensemble-Based Alzheimer's Disease Classification Using Features Extracted from Hog Descriptor and Pre-trained Models by Enver Akbacak, Nedim Muzoglu

    Published 2024-12-01
    “…Alzheimer's Disease is the most common type of dementia and is a progressive, neurodegenerative disease. …”
    Get full text
    Article
  16. 576

    Capgras syndrome, an interesting but rare phenomenon in Psychiatry: A case series by Arghya Halder, Sagarika Ray, Manish Kumar, Amit Kumar Bhattacharya

    Published 2024-12-01
    “…Although the phenomenon is known to occur as a part of other psychiatric disorders such as schizophrenia and mood disorders, it is not infrequently encountered in organic conditions such as cerebrovascular disease, dementia, and epilepsy. Thus, it is important to rule out any underlying organic etiology by the use of appropriate neuroimaging techniques whenever felt necessary. …”
    Get full text
    Article
  17. 577

    Treatment Tactics for Psychosis in Parkinson’s Disease: A Literature Review by Daiva Milmantienė

    Published 2024-12-01
    “…Pharmacological treatment may include antipsychotics (quetiapine, clozapine), dopamine D2 receptor antagonists, 5-HT2A receptor ligands, medications for dementia, anxiolytics, antidepressants, and gabapentin. …”
    Get full text
    Article
  18. 578
  19. 579

    Sarcopenia is a risk factor for postoperative delirium in geriatric hip fracture patients: a retrospective study by Yi-Ming Qi, Hao-Tao Li, Shi-Min Chang, Sun-Jun Hu, Shou-Chao Du, Chen-Dong Liu, Yong-Qian Chu, Yun-Feng Rui, Yun-Feng Rui

    Published 2025-01-01
    “…Results of multivariate analysis identified sarcopenia (OR: 2.457, 95% CI 1.226–4.923, p = 0.011), ASA > 2 (OR: 3.968, 95% CI 1.805–8.722, p = 0.001), dementia (OR: 3.912, 95% CI 1.390–11.014, p = 0.010) and coronary heart disease (OR: 2.176, 95% CI 1.044–4.538, p = 0.038) as independent risk factors for POD in geriatric hip fracture patients.ConclusionThe incidences of POD and sarcopenia in geriatric hip fracture patients are high. …”
    Get full text
    Article
  20. 580

    Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment by Katharina Bolsewig, Eline A. J. Willemse, Pascual Sánchez-Juan, Alberto Rábano, Minerva Martínez, James D. Doecke, Giovanni Bellomo, Lisa Vermunt, Daniel Alcolea, Steffen Halbgebauer, Sjors in ‘t Veld, Niklas Mattsson-Carlgren, Katerina Veverova, Christopher J. Fowler, Lynn Boonkamp, Marleen Koel-Simmelink, Zulaiga Hussainali, Daimy N. Ruiters, Lorenzo Gaetani, Andrea Toja, Juan Fortea, Yolande Pijnenburg, Afina W. Lemstra, Wiesje M. van der Flier, Jakub Hort, Markus Otto, Oskar Hansson, Lucilla Parnetti, Colin L. Masters, Alberto Lleó, Charlotte E. Teunissen, Marta Del Campo Milán

    Published 2025-01-01
    “…Here we evaluate plasma DDC, measured by proximity extension assay, and the effect of dopaminergic treatment in three independent LBD (with a focus on dementia with Lewy bodies (DLB) and Parkinson’s disease (PD)) cohorts: an autopsy-confirmed cohort (n = 71), a large multicenter, cross-dementia cohort (n = 1498) and a longitudinal cohort with detailed treatment information (n = 66, median follow-up time[IQR] = 4[4, 4] years). …”
    Get full text
    Article